PTK2 and neoplasm: Integrin β4 EGFR/Src signaling mediates the tyrosine phosphorylation of integrin β4, and then recruits FAK to integrin β4, leading to FAK activation and signal transduction, thereby activating the AKT signaling pathway and promoting tumor invasion [13,48,49].